---
title: "US FDA clears Elucid’s PlaqueIQ imaging analysis software"
date: "2024-10-01T13:30:58.000Z"
publishedDate: "1 octobre 2024"
summary: "Elucid has received 510(k) clearance from the US Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease. PlaqueIQ is a non-invasive software that can objectively quantify and classify plaque morphology based on ground-truth histology, and is designed to give physicians new, clinically validated information to help stratify [&#8230;] The post US FDA clears Elucid’s PlaqueIQ imaging analysis software appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-elucid-plaqueiq/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-01-us-fda-clears-elucids-plaqueiq-imaging-analysis-software"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/FDA_image_1_edited.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-elucid-plaqueiq/"
---

![US FDA clears Elucid’s PlaqueIQ imaging analysis software](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/FDA_image_1_edited.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-elucid-plaqueiq/*

## L’essentiel

Elucid has received 510(k) clearance from the US Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease. PlaqueIQ is a non-invasive software that can objectively quantify and classify plaque morphology based on ground-truth histology, and is designed to give physicians new, clinically validated information to help stratify [&#8230;] The post US FDA clears Elucid’s PlaqueIQ imaging analysis software appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/us-fda-elucid-plaqueiq/
